0000912061-20-000009.txt : 20200212 0000912061-20-000009.hdr.sgml : 20200212 20200212102745 ACCESSION NUMBER: 0000912061-20-000009 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20200212 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200212 DATE AS OF CHANGE: 20200212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL HEALTH TRENDS CORP CENTRAL INDEX KEY: 0000912061 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] IRS NUMBER: 592705336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36849 FILM NUMBER: 20601020 BUSINESS ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 BUSINESS PHONE: 852-3107-0800 MAIL ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 8-K 1 nhtc20200212_8k.htm 8-K Document
false0000912061 0000912061 2020-02-12 2020-02-12


UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
 
February 12, 2020
 
Date of Report (Date of earliest event reported)
 
 NATURAL HEALTH TRENDS CORP.
(Exact name of registrant as specified in its charter)
Delaware
001-36849
59-2705336
(State or other jurisdiction of incorporation)        
(Commission File Number)  
(IRS Employer Identification No.)
 
 
 

 Units 1205-07, 12F, Mira Place Tower A, 132 Nathan Road, Tsimshatsui, Kowloon, Hong Kong
(Address of principal executive offices, including zip code)

+852-3107-0800
(Registrant’s telephone number, including area code)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐   Emerging growth company

o    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
NHTC
The NASDAQ Stock Market LLC





Item 2.02 Results of Operations and Financial Condition.
 
On February 12, 2020, Natural Health Trends Corp. issued an earnings release announcing its results for the quarter and year ended December 31, 2019. The press release is attached hereto as exhibit 99.1.
 
Item 9.01 Financial Statements and Exhibits.
 
(d)
Exhibits.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: February 12, 2020
 
NATURAL HEALTH TRENDS CORP.
 
 
 
 
 
 
 
By:
/s/ Timothy S. Davidson                                                     
 
 
Timothy S. Davidson
 
 
Senior Vice President and Chief Financial Officer



 EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit
Exhibit 99.1

Natural Health Trends Reports Fourth Quarter and Full Year 2019 Financial Results

–
Fourth quarter 2019 revenue increased 5% from the prior quarter
–
Fourth quarter 2019 order volume increased 12% from the prior quarter
–
Generated positive cash flow from operations in the fourth quarter 2019
–
Repurchased $10.1 million of common stock and paid $7.3 million in dividends in 2019
–
Declared a quarterly cash dividend of $0.20 per share
–
Expect to realize $6.5 million in annualized cost savings in 2020

HONG KONG – February 12, 2020 – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the fourth quarter and full year ended December 31, 2019.

Fourth Quarter 2019 Financial Highlights

•
Revenue of $17.8 million decreased 57% compared to $41.6 million in the fourth quarter of 2018. Revenue increased 5% compared to $17.0 million in the third quarter of 2019.
•
Operating loss was $3.2 million compared to operating income of $5.7 million in the fourth quarter of 2018. Operating loss for the fourth quarter of 2019 included an impairment charge of $1.8 million upon the early adoption of a new accounting standard pertaining to goodwill that arose from a merger transaction in March 2004.
•
Net loss was $2.8 million, or $0.27 per diluted share, compared to net income of $5.6 million, or $0.49 per diluted share, in the fourth quarter of 2018.
•
The number of Active Members1 decreased 16% to 57,410 at December 31, 2019, compared to 68,150 at September 30, 2019, and decreased 41% compared to 97,840 at December 31, 2018.
1 
Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.

Full Year 2019 Financial Highlights

•
Revenue of $77.6 million decreased 60% compared to $191.9 million in 2018.
•
Operating loss was $7.0 million compared to operating income of $33.7 million in 2018. Operating loss included a goodwill impairment charge of $1.8 million in 2019.
•
Net loss was $5.6 million, or $0.52 per diluted share, compared to net income of $31.0 million, or $2.74 per diluted share, in 2018.


1


Management Commentary

“2019 was a challenging year for our business amid a host of macroeconomic and industry-specific factors that created a highly difficult operating environment,” commented Chris Sharng, President of Natural Health Trends Corp. “In addition to China’s 100 day campaign announced last January and negative sentiment stemming from social media as it relates to health products companies in China, additional developments such as ongoing global trade tensions, China’s slowing economy and civil unrest in Hong Kong further contributed to the decline in revenue for 2019. That said, order volume in the fourth quarter of 2019 increased 12% over the prior quarter as a result of our successful event in Macau, along with a positive response to our various product promotions and incentives.”

Mr. Sharng further commented, “While our first quarter results are typically affected by the Chinese New Year, the coronavirus outbreak and the unprecedented measures to control it are posing further challenges to the market. Following the extended Chinese New Year holidays, we plan to rely on product promotions and webcast training to overcome physical restrictions. We are continuing to monitor the evolving situation closely and will adapt our marketing programs accordingly. Looking ahead, we have implemented a strategy to more effectively manage elements within our control including: ensuring our incentives remain attractive to our leaders and member base; continuing to expand our operations into new geographies; and reducing our cost structure. To that end, we expect to achieve annualized cost savings of approximately $6.5 million in 2020.”

Balance Sheet and Cash Flow

•
Net cash provided by operating activities was $110,000 in the fourth quarter of 2019, compared to $4.4 million in the fourth quarter of 2018. For the full year of 2019, net cash used in operating activities was $18.6 million, compared to net cash provided by operating activities of $29.7 million in 2018.
•
Total cash and cash equivalents were $96.0 million as of December 31, 2019, down from $132.7 million as of December 31, 2018. The decrease in the cash balance was mainly due to a $16.1 million decrease in working capital, $10.1 million in stock repurchases and $7.3 million in dividend payments.
•
During the three months ended December 31, 2019, the Company purchased a total of 97,785 shares of its common stock for an aggregate purchase price of $552,000, plus transaction costs. As of December 31, 2019, $21.9 million of the stock repurchase program remained available for future purchases, inclusive of related estimated income tax.
•
On February 10, 2020, the Company’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on March 6, 2020 to stockholders of record as of February 25, 2020. Further, the Company expects to pay a comparable quarterly cash dividend in 2020 and 2021; however, future quarterly cash dividends will be at the sole discretion of the Board of Directors, and will depend on the Company's results of operations, financial condition, capital requirements and other factors considered relevant by the Board of Directors.

2



The Company expects to issue its 2019 audited financial results in March with its Annual Report on Form 10-K to be filed with the Securities and Exchange Commission. The financial results are preliminary and the accompanying financial statements have not been audited or have not yet been reviewed by the Company’s independent accountants. Significant updates and revisions may be required before the release of the Company’s 2019 audited financial results.

Fourth Quarter and Full Year 2019 Financial Results Conference Call

Management will host a conference call to discuss the fourth quarter and full year 2019 financial results today, Wednesday, February 12, 2020 at 11:30 a.m. Eastern Time. The conference call details are as follows:
Date:
Wednesday, February 12, 2020
Time:
11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
Dial-in:
1-877-407-0789 (Domestic)
1-201-689-8562 (International)
Conference ID:
13698060
Webcast:
http://public.viavid.com/index.php?id=137649
For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on February 12, 2020 through 11:59 p.m. Eastern Time on February 26, 2020 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number: 13698060.

About Natural Health Trends Corp.

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.

Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on April 26, 2019 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.


3


CONTACTS:

Company Contact:
Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (Hong Kong): +852-3107-0800
Tel (U.S.): 310-541-0888
scott.davidson@nhtglobal.com
         
Investor Contact:
ADDO Investor Relations
Tel: 310-829-5400
investor.relations@nhtglobal.com

4


NATURAL HEALTH TRENDS CORP.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data) 

 
December 31, 2019
 
December 31, 2018
 
(Unaudited)
 
 
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
96,035

 
$
132,653

Inventories
6,404

 
12,165

Other current assets
5,936

 
5,369

Total current assets
108,375

 
150,187

Property and equipment, net
735

 
934

Operating lease right-of-use assets
3,135

 
—

Goodwill
—

 
1,764

Restricted cash
3,390

 
2,998

Deferred tax asset
2,039

 
1,207

Other assets
823

 
831

Total assets
$
118,497

 
$
157,921

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
680

 
$
1,631

Accrued commissions
2,931

 
12,502

Other accrued expenses
2,387

 
6,121

Deferred revenue
4,506

 
6,795

Amounts held in eWallets
12,938

 
14,611

Operating lease liabilities
1,655

 
—

Other current liabilities
1,205

 
1,424

Total current liabilities
26,302

 
43,084

Income taxes payable
15,365

 
16,982

Deferred tax liability
202

 
186

Long-term incentive
—

 
7,808

Operating lease liabilities
1,564

 
—

Total liabilities
43,433

 
68,060

Stockholders’ equity:
 
 
 
Preferred stock
—

 
—

Common stock
13

 
13

Additional paid-in capital
86,102

 
86,415

Retained earnings
16,117

 
44,431

Accumulated other comprehensive loss
(1,264
)
 
(1,250
)
Treasury stock, at cost
(25,904
)
 
(39,748
)
Total stockholders’ equity
75,064

 
89,861

Total liabilities and stockholders’ equity
$
118,497

 
$
157,921



5


NATURAL HEALTH TRENDS CORP. 
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
 
 
Three Months Ended December 31,
 
Year Ended
December 31,
 
2019
 
2018
 
2019
 
2018
 
(Unaudited)
 
(Unaudited)
 
 
Net sales
$
17,835

 
$
41,590

 
$
77,614

 
$
191,910

Cost of sales
5,102

 
8,821

 
20,104

 
39,367

Gross profit
12,733

 
32,769

 
57,510

 
152,543

Operating expenses:
 
 
 
 
 
 
 
Commissions expense
7,291

 
20,211

 
35,549

 
87,502

Selling, general and administrative expenses
6,924

 
6,825

 
27,220

 
31,309

Goodwill impairment
1,764

 
—

 
1,764

 
—

Total operating expenses
15,979

 
27,036

 
64,533

 
118,811

Income (loss) from operations
(3,246
)
 
5,733

 
(7,023
)
 
33,732

Other income, net
298

 
324

 
1,426

 
789

Income (loss) before income taxes
(2,948
)
 
6,057

 
(5,597
)
 
34,521

Income tax provision (benefit)
(106
)
 
498

 
14

 
3,486

Net income (loss)
$
(2,842
)
 
$
5,559

 
$
(5,611
)
 
$
31,035

Net income (loss) per common share:
 
 
 
 
 
 
 
Basic
$
(0.27
)
 
$
0.49

 
$
(0.52
)
 
$
2.75

Diluted
$
(0.27
)
 
$
0.49

 
$
(0.52
)
 
$
2.74

Weighted-average number of common shares outstanding:
 
 
 
 
 
 
 
Basic
10,456

 
11,321

 
10,871

 
11,304

Diluted
10,456

 
11,329

 
10,871

 
11,318



6


NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
 
 
Year Ended December 31,
 
2019
 
2018
CASH FLOWS FROM OPERATING ACTIVITIES:
(Unaudited)
 
 
Net income (loss)
$
(5,611
)
 
$
31,035

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
 
 
 
Depreciation and amortization
387

 
424

Noncash lease expense
1,760

 
—

Deferred income taxes
(820
)
 
358

Goodwill impairment
1,764

 
—

Changes in assets and liabilities:
 
 
 
Inventories
5,820

 
(3,879
)
Other current assets
(554
)
 
2,065

Other assets
—

 
(55
)
Accounts payable
(953
)
 
(116
)
Accrued commissions
(9,598
)
 
1,410

Other accrued expenses
(2,797
)
 
(883
)
Deferred revenue
(2,315
)
 
2,359

Amounts held in eWallets
(1,742
)
 
(509
)
Operating lease liabilities
(1,807
)
 
—

Income taxes payable
(1,617
)
 
(2,077
)
Other current liabilities
(222
)
 
(326
)
Long-term incentive
(333
)
 
(96
)
Net cash provided by (used in) operating activities
(18,638
)
 
29,710

CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
Purchases of property and equipment
(189
)
 
(214
)
Net cash used in investing activities
(189
)
 
(214
)
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
Repurchase of common stock
(10,117
)
 
—

Dividends paid
(7,344
)
 
(31,512
)
Net cash used in financing activities
(17,461
)
 
(31,512
)
Effect of exchange rates on cash, cash equivalents and restricted cash
62

 
(811
)
Net decrease in cash, cash equivalents and restricted cash
(36,226
)
 
(2,827
)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period
135,651

 
138,478

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period
$
99,425

 
$
135,651

SUPPLEMENTAL DISCLOSURES OF OTHER CASH FLOW INFORMATION:
 
 
 
Issuance of treasury stock for employee awards, net
$
8,289

 
$
554

Right-of-use assets obtained in exchange for operating lease liabilities
$
5,082

 
$
—



7

 EX-101.SCH 3 nhtc-20200204.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 nhtc-20200204_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 nhtc-20200204_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 nhtc-20200204_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover page. Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, Address Line Three Entity Address, City or Town Entity Address, City or Town Entity Address, Country Entity Address, Country City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag EX-101.PRE 7 nhtc-20200204_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 nhtc20200212_8k_htm.xml IDEA: XBRL DOCUMENT 0000912061 2020-02-12 2020-02-12 false 0000912061 8-K 2020-02-12 NATURAL HEALTH TRENDS CORP. DE 001-36849 59-2705336 Units 1205-07, 12F Mira Place Tower A 132 Nathan Road Tsimshatsui HK 852 3107-0800 false false false false false Common Stock, par value $0.001 per share NHTC NASDAQ ZIP 10 0000912061-20-000009-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000912061-20-000009-xbrl.zip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end XML 12 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Cover Page
Feb. 12, 2020
Cover page.  
Document Type 8-K
Document Period End Date Feb. 12, 2020
Entity Registrant Name NATURAL HEALTH TRENDS CORP.
Entity Incorporation, State or Country Code DE
Entity File Number 001-36849
Entity Tax Identification Number 59-2705336
Entity Address, Address Line One Units 1205-07, 12F
Entity Address, Address Line Two Mira Place Tower A
Entity Address, Address Line Three 132 Nathan Road
Entity Address, City or Town Tsimshatsui
Entity Address, Country HK
City Area Code 852
Local Phone Number 3107-0800
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol NHTC
Security Exchange Name NASDAQ
Entity Central Index Key 0000912061
Amendment Flag false
XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 1 95 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Cover Page Sheet http://www.naturalhealthtrendscorp.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports nhtc20200212_8k.htm ex99-1.htm nhtc-20200204.xsd nhtc-20200204_cal.xml nhtc-20200204_def.xml nhtc-20200204_lab.xml nhtc-20200204_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } EXCEL 15 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 16 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nhtc20200212_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "nhtc-20200204_cal.xml" ] }, "definitionLink": { "local": [ "nhtc-20200204_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "nhtc20200212_8k.htm" ] }, "labelLink": { "local": [ "nhtc-20200204_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "nhtc-20200204_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "nhtc-20200204.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nhtc", "nsuri": "http://www.naturalhealthtrendscorp.com/20200204", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "nhtc20200212_8k.htm", "contextRef": "D2020Q1Feb12-Feb12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover Page", "role": "http://www.naturalhealthtrendscorp.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "nhtc20200212_8k.htm", "contextRef": "D2020Q1Feb12-Feb12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" }